Home › Trial NCT04146038
Salsalate, Venetoclax, and Decitabine or Azacitidine for the Treatment of Acute Myeloid Leukemia or Advanced Myelodysplasia/Myeloproliferative Disease
- Trial IDNCT04146038
- StatusCompleted
- PhasePhase 2
- Study typeInterventional
- SponsorRutgers, The State University of New Jersey
- Enrollment5
- Start date2020-10-26
- ConditionsAcute Myeloid Leukemia · Chronic Myelomonocytic Leukemia · Myeloblasts 10 Percent or More of Bone Marrow Nucleated Cells · Myelodysplastic Syndrome · Myeloproliferative Neoplasm · Recurrent Acute Myeloid Leukemia
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.